1. Home
  2. NXAT vs SCNI Comparison

NXAT vs SCNI Comparison

Compare NXAT & SCNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nexus Advanced Technologies Inc. Ordinary Shares

NXAT

Nexus Advanced Technologies Inc. Ordinary Shares

N/A

Current Price

$0.53

Market Cap

1.2M

ML Signal

N/A

Logo Scinai Immunotherapeutics Ltd.

SCNI

Scinai Immunotherapeutics Ltd.

SELL

Current Price

$1.70

Market Cap

1.2M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
NXAT
SCNI
Founded
2023
2003
Country
Cayman Islands
Israel
Employees
N/A
N/A
Industry
Movies/Entertainment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2M
1.2M
IPO Year
2023
2014

Fundamental Metrics

Financial Performance
Metric
NXAT
SCNI
Price
$0.53
$1.70
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 176.6K
139.8K
Earning Date
12-01-2026
08-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 50.00
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.22
$0.21
52 Week High
$1.23
$3.58

Technical Indicators

Market Signals
Indicator
NXAT
SCNI
Relative Strength Index (RSI) 57.16 77.77
Support Level $0.33 $0.31
Resistance Level $1.15 $1.76
Average True Range (ATR) 0.09 0.09
MACD 0.02 0.15
Stochastic Oscillator 59.35 92.40

Price Performance

Historical Comparison
NXAT
SCNI

About NXAT Nexus Advanced Technologies Inc. Ordinary Shares

Nexus Advanced Technologies Inc pursuing strategic investments, acquisitions, and partnerships across AI infrastructure and technologies. The Company's ideas include opportunities involving data centers, AI compute and GPU infrastructure, and other technologies supporting the development and deployment of artificial intelligence. Nexus seeks to combine access to capital, strategic partnerships, and technology opportunities to build a diversified platform positioned to participate in the continued growth of world-wide AI infrastructure.

About SCNI Scinai Immunotherapeutics Ltd.

Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units: (i) Scinai R&D, focused on the development of therapeutics in inflammation and immunology, and (ii) the contract development and manufacturing organization (CDMO) business. The CDMO business provides integrated development and manufacturing services to small and emerging biotech companies, supporting clients from early-stage development through clinical-stage production.

Share on Social Networks: